- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 8, 2017
Coverage of our peer-reviewed research in the healthcare and mainstream press.
A special report from Modern Healthcare on achieving transparency in healthcare highlighted a statistic from a study published in the February 2016 issue of The American Journal of Managed Care® (AJMC®). That study, titled “Characterizing Health Plan Price Estimator Tools: Findings From a National Survey,” found that just 45% of plans with cost-estimator tools used their negotiated rates with providers to calculate the estimate. Incorporating more complete data into transparency tools may increase their impact on consumers’ choices, the report stated.
MobiHealthNews published an article about health technology company AbleTo’s plans to use the $36.6 million in funding it has received from investors. The article referenced a study published in the February 2015 issue of AJMC® that demonstrated the platform’s ability to improve outcomes for health plan enrollees. “Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs” presented encouraging findings, including lower hospitalizations, among Aetna members receiving the AbleTo intervention.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
